ERBB2 and urinary bladder cancer: The urinary HER2/neu levels and the ratio of the urinary HER2/neu to creatinine were significantly higher in patients with bladder cancer (p=0.011, p=0.021, respectively) (Figures 1B and 1C) (Table-2).